21 U.S.C. § 360ddd-2 — Inapplicability of drug fees to designated medical gases
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
A designated medical gas , alone or in combination with another designated gas or gases (as medically appropriate) deemed under section 360ddd–1 of this title to have in effect an approved application shall not be assessed fees under section 379h(a) or 379j–12(a) of this title on the basis of such deemed approval. (June 25, 1938, ch. 675, § 577, as added Pub. L. 112–144, title XI, § 1111 , July 9, 2012 , 126 Stat. 1111 ; amended Pub. L. 114–255, div. A, title III, § 3101(a)(2)(T) , Dec. 13, 2016 , 130 Stat. 1155 .) Editorial Notes Amendments 2016— Pub. L. 114–255 inserted “or 379j–12(a)” after “section 379h(a)”.
Related documents
- 21 U.S.C. § 360ddd-1 — Regulation of medical gases#577304
- Are regulatory safety warnings effective in reducing medicine utilization according to Carracedo-Martinez et al. studies?#68611
- Are regulatory safety warnings effective in reducing medicine utilization according to Carracedo-Martinez et al. studies?#68610
- TOBacco STOP in Chronic Obstructive Pulmonary Disease-Trial - Study Protocol#1085795
- Association between venlafaxine use and the risk of withdrawal from nonopioid substances: a nationwide, population-based study.#954
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive